- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.28 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.1: 19 residues within 4Å:- Chain A: Y.43, F.44, H.46, F.47, H.59, K.62, V.63, A.66, L.84, L.87, H.88, L.92, V.94, N.98, F.99, L.102, V.133, L.137
- Ligands: CMO.2
17 PLIP interactions:17 interactions with chain A,- Hydrophobic interactions: A:F.44, A:F.44, A:A.66, A:L.84, A:L.84, A:L.87, A:L.92, A:V.94, A:F.99, A:V.133, A:L.137
- Salt bridges: A:H.46, A:H.59, A:K.62
- pi-Stacking: A:H.59, A:H.59
- Metal complexes: A:H.88
HEM.3: 19 residues within 4Å:- Chain B: T.39, F.42, F.43, F.46, H.64, K.67, A.71, F.72, L.89, L.92, H.93, L.97, V.99, N.103, F.104, L.107, V.138, L.142
- Ligands: CMO.4
20 PLIP interactions:19 interactions with chain B, 1 Ligand-Ligand interactions- Hydrophobic interactions: B:T.39, B:F.42, B:F.42, B:F.43, B:F.72, B:F.72, B:L.89, B:L.92, B:L.97, B:V.99, B:N.103, B:F.104, B:L.107, B:V.138, B:L.142
- Salt bridges: B:H.64
- pi-Stacking: B:H.64, B:H.93
- Metal complexes: B:H.93, CMO.4
HEM.5: 17 residues within 4Å:- Chain C: Y.43, F.44, F.47, H.59, K.62, V.63, L.84, L.87, H.88, L.92, V.94, N.98, F.99, L.102, V.133, L.137
- Ligands: CMO.6
16 PLIP interactions:16 interactions with chain C,- Hydrophobic interactions: C:Y.43, C:F.44, C:F.44, C:F.47, C:K.62, C:K.62, C:L.87, C:L.92, C:V.94, C:N.98, C:F.99, C:L.102, C:L.102, C:V.133, C:L.137
- Metal complexes: C:H.88
HEM.7: 17 residues within 4Å:- Chain D: F.42, F.43, H.64, K.67, V.68, A.71, F.72, L.89, L.92, H.93, L.97, V.99, N.103, F.104, L.107, V.138
- Ligands: CMO.8
18 PLIP interactions:18 interactions with chain D,- Hydrophobic interactions: D:F.42, D:F.42, D:F.43, D:F.43, D:V.68, D:A.71, D:F.72, D:L.89, D:L.89, D:L.92, D:L.97, D:V.99, D:F.104, D:L.107, D:V.138
- Water bridges: D:S.45
- Salt bridges: D:H.64
- Metal complexes: D:H.93
- 4 x CMO: CARBON MONOXIDE(Non-functional Binders)
CMO.2: 4 residues within 4Å:- Chain A: L.30, H.59, V.63
- Ligands: HEM.1
No protein-ligand interaction detected (PLIP)CMO.4: 4 residues within 4Å:- Chain B: F.43, H.64, V.68
- Ligands: HEM.3
No protein-ligand interaction detected (PLIP)CMO.6: 4 residues within 4Å:- Chain C: L.30, H.59, V.63
- Ligands: HEM.5
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:H.59
CMO.8: 5 residues within 4Å:- Chain D: L.29, F.43, H.64, V.68
- Ligands: HEM.7
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Funaki, R. et al., Genetically engineered haemoglobin wrapped covalently with human serum albumins as an artificial O2carrier. J Mater Chem B (2020)
- Release Date
- 2020-01-01
- Peptides
- Hemoglobin subunit alpha: AC
Hemoglobin subunit beta: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IC
KB
JD
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.28 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 4 x CMO: CARBON MONOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Funaki, R. et al., Genetically engineered haemoglobin wrapped covalently with human serum albumins as an artificial O2carrier. J Mater Chem B (2020)
- Release Date
- 2020-01-01
- Peptides
- Hemoglobin subunit alpha: AC
Hemoglobin subunit beta: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IC
KB
JD
L